ISRCTN ISRCTN11445521
DOI https://doi.org/10.1186/ISRCTN11445521
Secondary identifying numbers N/A
Submission date
26/01/2015
Registration date
20/02/2015
Last edited
08/03/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims:
The mechanisms involved in maintaining homoeostasis in the body decrease in obesity. Biomarkers might indicate the early metabolic and proinflammatory consequences of obesity. Bioactive compounds like n-3 PUFAs might prevent the decline in organ function in people who are obese. The aim in this study is to find out whether a combined intervention (diet and n-3 PUFA) alters the metabolic, inflammatory and genetic biomarkers in obese subjects.

Who can participate?
Adults who are and are not obese

What does the study involve?
After a detailed medical examination, all individuals will receive 2 weeks of an adaptation diet. Biochemical estimations (at fasting, postprandial tests, oral glucose and oral lipids tolerance tests and genetic tests) will be performed and then all subjects will be assigned to different diet groups (low calorie or isocaloric diet). Additionally, subjects will be randomly allocated to receive n-3 PUFA or placebo for 3 months. Every 2 weeks all subjects will receive intensive group and individual education about dietary habits. Medical examination and laboratory tests will be done.

What are the possible benefits and risks of participating?
The direct benefit for participants is detailed assessment of their health status—medical examination, laboratory tests and ultrasonography (if necessary). There is a very small chance of infection at the site of the insertion of the needle.

Where is the study run from?
Jagiellonian University Medical College (Poland)

When is the study starting and how long is it expected to run for?
From September 2009 to February 2015

Who is funding the study?
European Commission (Belgium)

Who is the main contact?
Professor Aldona Dembinska-Kiec
mbkiec@cyf-kr.edu.pl

Contact information

Dr Aldona Dembinska-Kiec
Scientific

Kopernika 15a
Krakow
31501
Poland

Phone +48 12 4214006
Email mbkiec@cyf-kr.edu.pl
Dr Malgorzata Malczewska-Malec
Scientific

Kopernika 15a
Krakow
31-501
Poland

ORCiD logoORCID ID 0000-0002-3522-0711
Phone +48 12 4214006
Email mbmalec@cyf-kr.edu.pl

Study information

Study designRandomised placebo-controlled double-blind single-centre study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typePrevention
Scientific titleCaloric restriction and postprandial stress markers in healthy and obese people taking n-3 polyunsaturated fatty acids: BIOmarkers of Robustness of Metabolic Homeostasis for Nutrigenomics-derived Health CLAIMS Made on Food
Study objectives1. The post-prandial metabolic and inflammatory biomarkers will be changed in obese compared with healthy, non-obese subjects.
2. Caloric restriction combined with n-3 polyunsaturated fatty acids (n-3 PUFA) supplementation will diminish the post-prandial metabolic and inflammatory responses.
3. The long-term supplementation with marine n-3 PUFA and low calorie diet will protect people from obesity-related complications.
Ethics approval(s)Jagiellonian University Bioethical Committee, 25/06/2009, KBET/82/B/2009
Health condition(s) or problem(s) studiedHealthy and obese subjects
Intervention1. Low calorie diet (1200–1500 kcal/day) or isocaloric diet combined marine n-3 PUFA (1.8 g/day) as oral supplements for 3 months
2. Low calorie diet (1200–1500 kcal/day) or isocaloric diet combined with oral placebo for 3 months

Blood samples will be taken at fasting and during postprandial lipids and glucose tolerance tests before and after the intervention.
Intervention typeSupplement
Primary outcome measure1. Changes in metabolic and inflammatory biochemical markers after 3 moths of diet and n-3 PUFA supplementation
2. Changes in lipids and glucose metabolism markers during postprandial state in obese patients before and after intervention
3. Changes in expression of genes in peripheral blood mononuclear cells before and after intervention
Secondary outcome measures1. Changes in serum glucose-dependent insulinotropic peptide during postprandial period and after diet and n-3 PUFA supplementation
2. Changes in osteocalcin serum concentrations after diet and n-3 PUFA supplementation
3. Lipidomic analysis in serum before and after intervention
4. Changes in serum adipokines and cytokines after diet and n-3 PUFA supplementation
5. Association of gene polymorphisms with response to diet and n-3 PUFA supplementation
Overall study start date01/09/2009
Completion date28/02/2015

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants150 subjects
Total final enrolment48
Key inclusion criteria1. Age 25–65 years old
2. Body-mass index (BMI) 25–40 kg/m2
3. Not consuming fish oil or antioxidants
4. Willing to adhere to the study protocol
5. Able to provide written infomed consent
Key exclusion criteria1. Age < 25 years old or > 65 years old
2. BMI < 25 kg/m2 or > 40 kg/m2
3. Diabetes or other endocrine disorders
4. Chronic diseases (e.g., gastrointestinal problems, kidney diseases, liver diseases or cardiovascular problems)
5. Pregnant or planning to become pregnant during the study
6. Use of prescribed medications to control inflammation, blood lipids and glucose
7. Use of fish oil or other diet supplements
Date of first enrolment01/09/2009
Date of final enrolment31/07/2013

Locations

Countries of recruitment

  • Poland

Study participating centre

Jagiellonian University Medical College
Kopernika 15a
Krakow
31-501
Poland

Sponsor information

Jagiellonian University Medical College
University/education

Sw Anny 12
Krakow
30-006
Poland

ROR logo "ROR" https://ror.org/03bqmcz70

Funders

Funder type

Government

European Commission (Belgium)

No information available

Results and Publications

Intention to publish date05/03/2015
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planPlanning to submit manuscripts within 1 month and 6 months
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 22/05/2015 15/02/2022 Yes No
Results article 02/09/2021 08/03/2023 Yes No
Results article 16/08/2022 08/03/2023 Yes No

Editorial Notes

08/03/2023: Publication references added.
15/02/2022: Publication reference and total final enrolment added.